Pharmacology, Toxicology and Pharmaceutical Science
Cancer Growth
100%
Epidermal Growth Factor Receptor
100%
Reduced Nicotinamide Adenine Dinucleotide Dehydrogenase (Ubiquinone)
88%
Growth Factor Receptor
88%
Progesterone
88%
Malignant Neoplasm
44%
Neoplasm
44%
Clinical Trial
22%
Heme
22%
Tumor Growth
22%
Carcinogenesis
11%
Erlotinib
11%
Breast Cancer
11%
Biological Activity
11%
Anticarcinogen
11%
Cetuximab
11%
Ovary Cancer
11%
Colon Carcinoma
11%
Biochemistry, Genetics and Molecular Biology
Small Molecule
100%
Epidermal Growth Factor Receptor
100%
Growth Factor Receptor
88%
Progesterone
88%
Cancer Cell
22%
Clinical Trial
22%
Tumor Progression
22%
Drive
11%
Wild Type
11%
Colon
11%
Signal Transduction
11%
Oxidation Reduction Reaction
11%
Erlotinib
11%
Drug Sensitivity
11%
Cetuximab
11%
Cell Membrane
11%
Cell Death
11%
Cell Growth
11%
Carcinogenesis
11%
Biological Activity
11%
Anticancer
11%